University CN

Guangdong Pharmaceutical University

Papers we track 1,294
Since 2004
Most active in Transition Metal Complexes for Anticancer Therapy and DNA Interaction

Research trend share of all papers we track, per year

lower coverage before 2010 0.00% 0.01% 0.02% 2010 2020 2004: 0.002% (2 papers) 2005: 0.002% (3 papers) 2006: 0.002% (3 papers) 2007: 0.005% (7 papers) 2008: 0.007% (9 papers) 2009: 0.012% (21 papers) 2010: 0.010% (17 papers) 2011: 0.017% (22 papers) 2012: 0.010% (17 papers) 2013: 0.010% (27 papers) 2014: 0.011% (30 papers) 2015: 0.010% (35 papers) 2016: 0.016% (53 papers) 2017: 0.013% (23 papers) 2018: 0.014% (20 papers) 2019: 0.013% (27 papers) 2020: 0.015% (135 papers) 2021: 0.015% (151 papers) 2022: 0.015% (139 papers) 2023: 0.014% (153 papers) 2024: 0.013% (148 papers) 2025: 0.014% (150 papers) 2026: 0.014% (98 papers) — year in progress

Each point is this institution's share of the papers credited to all institutions that year, with credit split across co-authoring institutions. A share, not a count, because our collection grows unevenly by year. Hover a point for the figures. The hollow point is the year in progress.

Where it works most top research communities, by papers

Check communities to show the trend above for them only. Positions are by fractional papers across all years. A community page ranks its institutions by citation-weighted credit, so its order can differ.

Covers the materials and chemistry research Elements Live tracks, not everything Guangdong Pharmaceutical University publishes. Institutions come from OpenAlex affiliations, rolled up to the parent organisation. Older papers often lack affiliations, so earlier years undercount.